Baird Medical Issues Statement Regarding Recent Share Price Volatility
Globe Newswire•04/11/2026•16:02 ET
0
Key Highlights
- ➤Baird Medical (BDMD) says it is unaware of any material undisclosed reason for share-price decline
- ➤Baird Medical says current market valuation does not reflect underlying fundamentals and growth potential
- ➤FDA-cleared MWA system is being launched in the U.S. for benign thyroid nodules
- ➤Baird Medical is expanding its portfolio with IRE products and an AI-powered robotic ablation system
NEW YORK, Nov. 04, 2026 (GLOBE NEWSWIRE) -- Baird Medical Investment Holdings Limited (NASDAQ: BDMD) (“Baird Medical” or the “Company”), a healthcare innovator dedicated to microwave ablation (MWA) technology, has provided the following statement regarding recent volatility in the market price of its ordinary shares.
The Company is closely monitoring these fluctuations in the market price of its ordinary shares and the associated trading activity, and is not currently aware of any material development or otherwise undisclosed reason that would explain the recent decline in its ordinary share price.
Get started
Create a free account to read the full story.